The global Complement Targeted Therapeutics market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The complement system is a part of the immune system that enhances, or complements, the ability of antibodies to clear small organisms or damaged cells from an organism, promote inflammation and attack the pathogen?s cell membrane. While the complement system is essential to maintaining health, it can also become over-activated, contributing to the development of numerous devastating diseases.
This report aims to provide a comprehensive presentation of the global market for Complement Targeted Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Complement Targeted Therapeutics. This report contains market size and forecasts of Complement Targeted Therapeutics in global, including the following market information:
- Global Complement Targeted Therapeutics Market Revenue, 2018-2023, 2024-2030, ($ millions)
- Global top five companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Paroxysmal Nocturnal Haemoglobinuria Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Complement Targeted Therapeutics include Creative Biolabs, Novartis AG, Alexion Pharmaceuticals, Merck, Pfizer, Allergan and AbbVie, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Complement Targeted Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Complement Targeted Therapeutics Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Complement Targeted Therapeutics Market Segment Percentages, by Type, 2022 (%)
- Paroxysmal Nocturnal Haemoglobinuria
- Atypical Haemolytic Uraemic Syndrome (AHUS)
Global Complement Targeted Therapeutics Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Complement Targeted Therapeutics Market Segment Percentages, by Application, 2022 (%)
- Hospital Pharmacies
- Retail Pharamacies
- Online Pharmacies
Global Complement Targeted Therapeutics Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Complement Targeted Therapeutics Market Segment Percentages, By Region and Country, 2022 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Complement Targeted Therapeutics revenues in global market, 2018-2023 (estimated), ($ millions)
- Key companies Complement Targeted Therapeutics revenues share in global market, 2022 (%)
Key players include:
- Creative Biolabs
- Novartis AG
- Alexion Pharmaceuticals
- Merck
- Pfizer
- Allergan
- AbbVie
Outline of Major Chapters:
Chapter 1: Introduces the definition of Complement Targeted Therapeutics, market overview.
Chapter 2: Global Complement Targeted Therapeutics market size in revenue.
Chapter 3: Detailed analysis of Complement Targeted Therapeutics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Complement Targeted Therapeutics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Complement Targeted Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Complement Targeted Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Complement Targeted Therapeutics Overall Market Size
2.1 Global Complement Targeted Therapeutics Market Size: 2022 VS 2030
2.2 Global Complement Targeted Therapeutics Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Complement Targeted Therapeutics Players in Global Market
3.2 Top Global Complement Targeted Therapeutics Companies Ranked by Revenue
3.3 Global Complement Targeted Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Complement Targeted Therapeutics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Complement Targeted Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Complement Targeted Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Complement Targeted Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Complement Targeted Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Complement Targeted Therapeutics Market Size Markets, 2022 & 2030
4.1.2 Paroxysmal Nocturnal Haemoglobinuria
4.1.3 Atypical Haemolytic Uraemic Syndrome (AHUS)
4.2 By Type - Global Complement Targeted Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Complement Targeted Therapeutics Revenue, 2018-2023
4.2.2 By Type - Global Complement Targeted Therapeutics Revenue, 2024-2030
4.2.3 By Type - Global Complement Targeted Therapeutics Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Complement Targeted Therapeutics Market Size, 2022 & 2030
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharamacies
5.1.4 Online Pharmacies
5.2 By Application - Global Complement Targeted Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Complement Targeted Therapeutics Revenue, 2018-2023
5.2.2 By Application - Global Complement Targeted Therapeutics Revenue, 2024-2030
5.2.3 By Application - Global Complement Targeted Therapeutics Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Complement Targeted Therapeutics Market Size, 2022 & 2030
6.2 By Region - Global Complement Targeted Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Complement Targeted Therapeutics Revenue, 2018-2023
6.2.2 By Region - Global Complement Targeted Therapeutics Revenue, 2024-2030
6.2.3 By Region - Global Complement Targeted Therapeutics Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Complement Targeted Therapeutics Revenue, 2018-2030
6.3.2 US Complement Targeted Therapeutics Market Size, 2018-2030
6.3.3 Canada Complement Targeted Therapeutics Market Size, 2018-2030
6.3.4 Mexico Complement Targeted Therapeutics Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Complement Targeted Therapeutics Revenue, 2018-2030
6.4.2 Germany Complement Targeted Therapeutics Market Size, 2018-2030
6.4.3 France Complement Targeted Therapeutics Market Size, 2018-2030
6.4.4 U.K. Complement Targeted Therapeutics Market Size, 2018-2030
6.4.5 Italy Complement Targeted Therapeutics Market Size, 2018-2030
6.4.6 Russia Complement Targeted Therapeutics Market Size, 2018-2030
6.4.7 Nordic Countries Complement Targeted Therapeutics Market Size, 2018-2030
6.4.8 Benelux Complement Targeted Therapeutics Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Complement Targeted Therapeutics Revenue, 2018-2030
6.5.2 China Complement Targeted Therapeutics Market Size, 2018-2030
6.5.3 Japan Complement Targeted Therapeutics Market Size, 2018-2030
6.5.4 South Korea Complement Targeted Therapeutics Market Size, 2018-2030
6.5.5 Southeast Asia Complement Targeted Therapeutics Market Size, 2018-2030
6.5.6 India Complement Targeted Therapeutics Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Complement Targeted Therapeutics Revenue, 2018-2030
6.6.2 Brazil Complement Targeted Therapeutics Market Size, 2018-2030
6.6.3 Argentina Complement Targeted Therapeutics Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Complement Targeted Therapeutics Revenue, 2018-2030
6.7.2 Turkey Complement Targeted Therapeutics Market Size, 2018-2030
6.7.3 Israel Complement Targeted Therapeutics Market Size, 2018-2030
6.7.4 Saudi Arabia Complement Targeted Therapeutics Market Size, 2018-2030
6.7.5 UAE Complement Targeted Therapeutics Market Size, 2018-2030
7 Complement Targeted Therapeutics Companies Profiles
7.1 Creative Biolabs
7.1.1 Creative Biolabs Company Summary
7.1.2 Creative Biolabs Business Overview
7.1.3 Creative Biolabs Complement Targeted Therapeutics Major Product Offerings
7.1.4 Creative Biolabs Complement Targeted Therapeutics Revenue in Global Market (2018-2023)
7.1.5 Creative Biolabs Key News & Latest Developments
7.2 Novartis AG
7.2.1 Novartis AG Company Summary
7.2.2 Novartis AG Business Overview
7.2.3 Novartis AG Complement Targeted Therapeutics Major Product Offerings
7.2.4 Novartis AG Complement Targeted Therapeutics Revenue in Global Market (2018-2023)
7.2.5 Novartis AG Key News & Latest Developments
7.3 Alexion Pharmaceuticals
7.3.1 Alexion Pharmaceuticals Company Summary
7.3.2 Alexion Pharmaceuticals Business Overview
7.3.3 Alexion Pharmaceuticals Complement Targeted Therapeutics Major Product Offerings
7.3.4 Alexion Pharmaceuticals Complement Targeted Therapeutics Revenue in Global Market (2018-2023)
7.3.5 Alexion Pharmaceuticals Key News & Latest Developments
7.4 Merck
7.4.1 Merck Company Summary
7.4.2 Merck Business Overview
7.4.3 Merck Complement Targeted Therapeutics Major Product Offerings
7.4.4 Merck Complement Targeted Therapeutics Revenue in Global Market (2018-2023)
7.4.5 Merck Key News & Latest Developments
7.5 Pfizer
7.5.1 Pfizer Company Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Complement Targeted Therapeutics Major Product Offerings
7.5.4 Pfizer Complement Targeted Therapeutics Revenue in Global Market (2018-2023)
7.5.5 Pfizer Key News & Latest Developments
7.6 Allergan
7.6.1 Allergan Company Summary
7.6.2 Allergan Business Overview
7.6.3 Allergan Complement Targeted Therapeutics Major Product Offerings
7.6.4 Allergan Complement Targeted Therapeutics Revenue in Global Market (2018-2023)
7.6.5 Allergan Key News & Latest Developments
7.7 AbbVie
7.7.1 AbbVie Company Summary
7.7.2 AbbVie Business Overview
7.7.3 AbbVie Complement Targeted Therapeutics Major Product Offerings
7.7.4 AbbVie Complement Targeted Therapeutics Revenue in Global Market (2018-2023)
7.7.5 AbbVie Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Complement Targeted Therapeutics Market Opportunities & Trends in Global Market
Table 2. Complement Targeted Therapeutics Market Drivers in Global Market
Table 3. Complement Targeted Therapeutics Market Restraints in Global Market
Table 4. Key Players of Complement Targeted Therapeutics in Global Market
Table 5. Top Complement Targeted Therapeutics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Complement Targeted Therapeutics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Complement Targeted Therapeutics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Complement Targeted Therapeutics Product Type
Table 9. List of Global Tier 1 Complement Targeted Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Complement Targeted Therapeutics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Complement Targeted Therapeutics Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Complement Targeted Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Complement Targeted Therapeutics Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Complement Targeted Therapeutics Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Complement Targeted Therapeutics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Complement Targeted Therapeutics Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Complement Targeted Therapeutics Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Complement Targeted Therapeutics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Complement Targeted Therapeutics Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Complement Targeted Therapeutics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Complement Targeted Therapeutics Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Complement Targeted Therapeutics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Complement Targeted Therapeutics Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Complement Targeted Therapeutics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Complement Targeted Therapeutics Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Complement Targeted Therapeutics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Complement Targeted Therapeutics Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Complement Targeted Therapeutics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Complement Targeted Therapeutics Revenue, (US$, Mn), 2024-2030
Table 30. Creative Biolabs Company Summary
Table 31. Creative Biolabs Complement Targeted Therapeutics Product Offerings
Table 32. Creative Biolabs Complement Targeted Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 33. Creative Biolabs Key News & Latest Developments
Table 34. Novartis AG Company Summary
Table 35. Novartis AG Complement Targeted Therapeutics Product Offerings
Table 36. Novartis AG Complement Targeted Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 37. Novartis AG Key News & Latest Developments
Table 38. Alexion Pharmaceuticals Company Summary
Table 39. Alexion Pharmaceuticals Complement Targeted Therapeutics Product Offerings
Table 40. Alexion Pharmaceuticals Complement Targeted Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 41. Alexion Pharmaceuticals Key News & Latest Developments
Table 42. Merck Company Summary
Table 43. Merck Complement Targeted Therapeutics Product Offerings
Table 44. Merck Complement Targeted Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 45. Merck Key News & Latest Developments
Table 46. Pfizer Company Summary
Table 47. Pfizer Complement Targeted Therapeutics Product Offerings
Table 48. Pfizer Complement Targeted Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 49. Pfizer Key News & Latest Developments
Table 50. Allergan Company Summary
Table 51. Allergan Complement Targeted Therapeutics Product Offerings
Table 52. Allergan Complement Targeted Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 53. Allergan Key News & Latest Developments
Table 54. AbbVie Company Summary
Table 55. AbbVie Complement Targeted Therapeutics Product Offerings
Table 56. AbbVie Complement Targeted Therapeutics Revenue (US$, Mn) & (2018-2023)
Table 57. AbbVie Key News & Latest Developments
List of Figures
Figure 1. Complement Targeted Therapeutics Segment by Type in 2022
Figure 2. Complement Targeted Therapeutics Segment by Application in 2022
Figure 3. Global Complement Targeted Therapeutics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Complement Targeted Therapeutics Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Complement Targeted Therapeutics Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Complement Targeted Therapeutics Revenue in 2022
Figure 8. By Type - Global Complement Targeted Therapeutics Revenue Market Share, 2018-2030
Figure 9. By Application - Global Complement Targeted Therapeutics Revenue Market Share, 2018-2030
Figure 10. By Type - Global Complement Targeted Therapeutics Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Complement Targeted Therapeutics Revenue Market Share, 2018-2030
Figure 12. By Application - Global Complement Targeted Therapeutics Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Complement Targeted Therapeutics Revenue Market Share, 2018-2030
Figure 14. By Region - Global Complement Targeted Therapeutics Revenue Market Share, 2018-2030
Figure 15. By Country - North America Complement Targeted Therapeutics Revenue Market Share, 2018-2030
Figure 16. US Complement Targeted Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Complement Targeted Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Complement Targeted Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Complement Targeted Therapeutics Revenue Market Share, 2018-2030
Figure 20. Germany Complement Targeted Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 21. France Complement Targeted Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Complement Targeted Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Complement Targeted Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Complement Targeted Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Complement Targeted Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Complement Targeted Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Complement Targeted Therapeutics Revenue Market Share, 2018-2030
Figure 28. China Complement Targeted Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Complement Targeted Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Complement Targeted Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Complement Targeted Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 32. India Complement Targeted Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Complement Targeted Therapeutics Revenue Market Share, 2018-2030
Figure 34. Brazil Complement Targeted Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Complement Targeted Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Complement Targeted Therapeutics Revenue Market Share, 2018-2030
Figure 37. Turkey Complement Targeted Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Complement Targeted Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Complement Targeted Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Complement Targeted Therapeutics Revenue, (US$, Mn), 2018-2030
Figure 41. Creative Biolabs Complement Targeted Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Novartis AG Complement Targeted Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Alexion Pharmaceuticals Complement Targeted Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Merck Complement Targeted Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Pfizer Complement Targeted Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Allergan Complement Targeted Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. AbbVie Complement Targeted Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
